Related references
Note: Only part of the references are listed.Microglial Activation Damages Dopaminergic Neurons through MMP-2/-9-Mediated Increase of Blood-Brain Barrier Permeability in a Parkinson's Disease Mouse Model
Zhengzheng Ruan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
SUN11602, a bFGF mimetic, modulated neuroinflammation, apoptosis and calcium-binding proteins in an in vivo model of MPTP-induced nigrostriatal degeneration
Alessio Ardizzone et al.
JOURNAL OF NEUROINFLAMMATION (2022)
GSK343, an Inhibitor of Enhancer of Zeste Homolog 2, Reduces Glioblastoma Progression through Inflammatory Process Modulation: Focus on Canonical and Non-Canonical NF-κB/IκBα Pathways
Sarah Adriana Scuderi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
EZH2 inhibition decreases neuroblastoma proliferation and in vivo tumor growth
Laura Bownes et al.
PLOS ONE (2021)
Histone Methylation Regulation in Neurodegenerative Disorders
Balapal S. Basavarajappa et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
The protective role of Prolyl oligopeptidase (POP) inhibition in acute lung injury induced by intestinal ischemia-reperfusion
Giovanna Casili et al.
Oncotarget (2021)
Reversing Epigenetic Gene Silencing to Overcome Immune Evasion in CNS Malignancies
Nivedita M. M. Ratnam et al.
FRONTIERS IN ONCOLOGY (2021)
The Multiple Roles of Sphingomyelin in Parkinson's Disease
Paola Signorelli et al.
BIOMOLECULES (2021)
Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology
David K. Simon et al.
CLINICS IN GERIATRIC MEDICINE (2020)
Parkinson disease
R. Balestrino et al.
EUROPEAN JOURNAL OF NEUROLOGY (2020)
Increased EZH2 Levels in Anterior Cingulate Cortex Microglia Aggravate Neuropathic Pain by Inhibiting Autophagy Following Brachial Plexus Avulsion in Rats
Xiang-Lei Meng et al.
NEUROSCIENCE BULLETIN (2020)
EZH2 is involved in vulnerability to neuroinflammation and depression -like behaviors induced by chronic stress in different aged mice
Wei Wang et al.
JOURNAL OF AFFECTIVE DISORDERS (2020)
EZH2: a novel target for cancer treatment
Ran Duan et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
TLR7/8 in the Pathogenesis of Parkinson's Disease
Michela Campolo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes
Hyuk Sung Kwon et al.
TRANSLATIONAL NEURODEGENERATION (2020)
Modulation of NLRP3 Inflammasome Attenuated Inflammatory Response Associated to Diarrhea-Predominant Irritable Bowel Syndrome
Sarah Adriana Scuderi et al.
BIOMEDICINES (2020)
Inhibition of EZH2 (Enhancer of Zeste Homolog 2) Attenuates Neuroinflammation via H3k27me3/SOCS3/TRAF6/NF-κB (Trimethylation of Histone 3 Lysine 27/Suppressor of Cytokine Signaling 3/Tumor Necrosis Factor Receptor Family 6/Nuclear Factor-κB) in a Rat Model of Subarachnoid Hemorrhage
Yujie Luo et al.
STROKE (2020)
Human tyrosine hydroxylase in Parkinson's disease and in related disorders
Toshiharu Nagatsu et al.
JOURNAL OF NEURAL TRANSMISSION (2019)
LRRK2 modifies α-syn pathology and spread in mouse models and human neurons
Gregor Bieri et al.
ACTA NEUROPATHOLOGICA (2019)
m6A Regulates Neurogenesis and Neuronal Development by Modulating Histone Methyltransferase Ezh2
Junchen Chen et al.
GENOMICS PROTEOMICS & BIOINFORMATICS (2019)
IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson's disease
Zhan Liu et al.
BRAIN BEHAVIOR AND IMMUNITY (2019)
Targeting EZH2 histone methyltransferase activity alleviates experimental intestinal inflammation
Jie Zhou et al.
NATURE COMMUNICATIONS (2019)
Epigenetic regulation of astrocyte function in neuroinflammation and neurodegeneration
Matthew Neal et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
Macrophage/microglial Ezh2 facilitates autoimmune inflammation through inhibition of Socs3
Xingli Zhang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Epigenetic Modifications Associated to Neuroinflammation and Neuropathic Pain After Neural Trauma
Clara Penas et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2018)
(-)-Epigallocatechin-3-gallate and EZH2 inhibitor GSK343 have similar inhibitory effects and mechanisms of action on colorectal cancer cells
Le Ying et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2018)
EZH2 REGULATES SPINAL NEUROINFLAMMATION IN RATS WITH NEUROPATHIC PAIN
Ruchi Yadav et al.
NEUROSCIENCE (2017)
The EZH2 inhibitor GSK343 suppresses cancer stem-like phenotypes and reverses mesenchymal transition in glioma cells
Tianfu Yu et al.
ONCOTARGET (2017)
Parkinson disease
Werner Poewe et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Biological networks in Parkinson's disease: an insight into the epigenetic mechanisms associated with this disease
Paulami Chatterjee et al.
BMC GENOMICS (2017)
The Neuroprotective Effect of Dimethyl Fumarate in an MPTP-Mouse Model of Parkinson's Disease: Involvement of Reactive Oxygen Species/Nuclear Factor-κB/Nuclear Transcription Factor Related to NF-E2
Michela Campolo et al.
ANTIOXIDANTS & REDOX SIGNALING (2017)
Selective inhibition of EZH2 by a small molecule inhibitor regulates microglial gene expression essential for inflammation
Sarder Arifuzzaman et al.
BIOCHEMICAL PHARMACOLOGY (2017)
Damage to dopaminergic neurons is mediated by proliferating cell nuclear antigen through the p53 pathway under conditions of oxidative stress in a cell model of Parkinson's disease
Da-Wei Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2016)
Epidemiology of Parkinson Disease
Andrea Lee et al.
NEUROLOGIC CLINICS (2016)
Traumatic Brain Injury Leads to Development of Parkinson's Disease Related Pathology in Mice
Daniela Impellizzeri et al.
FRONTIERS IN NEUROSCIENCE (2016)
Alterations of Myelin Content in Parkinson's Disease: A Cross-Sectional Neuroimaging Study
Douglas C. Dean et al.
PLOS ONE (2016)
Epigenetic mechanisms in Parkinson's disease
Ya Feng et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2015)
The Lewy Body in Parkinson's Disease and Related Neurodegenerative Disorders
Koichi Wakabayashi et al.
MOLECULAR NEUROBIOLOGY (2013)
Mechanisms of dopamine transporter regulation in normal and disease states
Roxanne A. Vaughan et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2013)
Apoptosis Signal-Regulating Kinase 1 Mediates MPTP Toxicity and Regulates Glial Activation
Kang-Woo Lee et al.
PLOS ONE (2012)
Neuroprotective Activities of Palmitoylethanolamide in an Animal Model of Parkinson's Disease
Emanuela Esposito et al.
PLOS ONE (2012)
Transcriptional Factor NF-kappa B as a Target for Therapy in Parkinson's Disease
Patrick M. Flood et al.
PARKINSONS DISEASE (2011)
Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice
Eriko Aoki et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2009)
Neuroinflammation in Parkinson's disease: a target for neuroprotection?
Etienne C. Hirsch et al.
LANCET NEUROLOGY (2009)
Microglial cells and Parkinson's disease
Li Qian et al.
IMMUNOLOGIC RESEARCH (2008)
Cellular pathology of Parkinson's disease: astrocytes, microglia and inflammation
P Teismann et al.
CELL AND TISSUE RESEARCH (2004)